Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by InterOcean Capital Group LLC

InterOcean Capital Group LLC grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 47.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,568 shares of the biotechnology company’s stock after acquiring an additional 502 shares during the period. InterOcean Capital Group LLC’s holdings in Axon Enterprise were worth $491,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in AXON. Norges Bank acquired a new position in Axon Enterprise during the 4th quarter worth $195,406,000. Motley Fool Asset Management LLC grew its holdings in Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock worth $153,981,000 after acquiring an additional 346,838 shares in the last quarter. Vanguard Group Inc. grew its holdings in Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after acquiring an additional 212,401 shares in the last quarter. International Assets Investment Management LLC acquired a new position in Axon Enterprise during the 4th quarter worth $39,907,000. Finally, Goldman Sachs Group Inc. grew its holdings in Axon Enterprise by 110.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company’s stock worth $71,302,000 after acquiring an additional 144,568 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.7 %

AXON traded down $2.30 on Thursday, reaching $310.81. 378,973 shares of the company traded hands, compared to its average volume of 489,647. The stock’s 50 day moving average price is $293.65 and its 200-day moving average price is $291.18. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The company has a market cap of $23.46 billion, a price-to-earnings ratio of 91.55, a PEG ratio of 7.20 and a beta of 0.95. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. During the same period in the previous year, the firm posted $0.51 earnings per share. The firm’s revenue was up 34.3% on a year-over-year basis. On average, sell-side analysts expect that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total transaction of $95,501.56. Following the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total transaction of $95,501.56. Following the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Joshua Isner sold 44,000 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the transaction, the president now directly owns 275,843 shares in the company, valued at $85,500,296.28. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,447 shares of company stock valued at $27,684,677. Corporate insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on AXON shares. Barclays boosted their price target on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 8th. JMP Securities reiterated a “market outperform” rating and issued a $375.00 target price on shares of Axon Enterprise in a report on Tuesday, May 7th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Finally, Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $342.54.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.